Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Vir Biotechnology Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 18 May 2023 | Vir Biotechnology Inc Enters Phase I Clinical Trial Agreement with Quest Life Sciences Pvt Ltd for elebsiran (GDCT0487007) | Contract Service Agreement |
Vir Biotechnology Inc
|
Quest Life Sciences Pvt Ltd
|
| 04 Oct 2022 | Vir Biotechnology Inc Enters Phase I/II Clinical Trial Agreement with Novotech Australia Pty Ltd for elebsiran, tobevibart (GDCT0455967) | Contract Service Agreement |
Vir Biotechnology Inc
Vir Biotechnology Inc |
Novotech Australia Pty Ltd
Novotech Australia Pty Ltd
|
| 11 Jul 2021 | Vir Biotechnology Inc Enters Phase II Clinical Trial Agreement with PPD Inc for elebsiran, tobevibart (GDCT0394869) | Contract Service Agreement |
Vir Biotechnology Inc
|
PPD Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer